The major targets for molecular diagnosis in gliomas are IDH, tumor suppressor protein TP53, phosphatase and tensin homolog (PTEN), telomerase reverse transcriptase (TERT), α-thalassemia/mental retardation syndrome X-linked (ATR-X), and epidermal growth factor receptor (EGFR). This evidence concerns the gene TP53 and glioma.